Show notes
GUEST INTRO Dr. Linda Strause, Ph.D has a doctorate in Neurophysiology and Biochemistry. She is currently the President of two companies and is using her talents to ensure the vision of creating synthetic psilocybin (PSLY.com) that can be used with therapy in Virtual Reality (EI.Ventures) comes to fruition. In this very interesting conversation, we discuss how the FDA works, how researchers conduct trials, how society is shifting it's attitude towards psychedelics, and why she believes in psilocybin (magic mushrooms) as a potential healer alongside therapy. JOIN OUR DISCORDhttps://discord.gg/welivetobuildWHAT YOU LEARN How the FDA works How researchers conduct trials How society is shifting its attitude towards psychedelics Why she believes in psilocybin (magic mushrooms) as a potential healer alongside therapy And much more! EPISODE LINKS Website: PSLY.com Website: https://www.ei.ventures TIMESTAMPS0:00 - Guest Introduction2:41 - Get to know Dr. Linda4:57 - Why Linda chose to work in the psychedelic space7:52 - Is the psychedelic space going to take off soon?14:42 - What is the process before you can do clinical trial18:34 - How are they going to conduct testing in the future20:50 - Conventional medicine vs psychedelic treatment26:10 - Mushrooms are starting to get FDA approved28:16 - The benefits of microdosing31:30 - Our roots with hallucinogenic plants36:40 - Follow up with Dr. Linda37:22 - Food nutrition and its importance40:54 - Exercise and heathy diet work as a pair WATCH ON YOUTUBEhttps://www.youtube.com/channel/UCRxmA5Mnz8sWx5mYD6l5HMA Hosted on Acast. See acast.com/privacy for more information.
